【天天新視野】歐盟評估哺乳山羊、羔羊及牛犢皺胃中凝乳酶和胃蛋白酶A的安全性
(相關資料圖)
2022年12月2日,歐盟食品安全局就食品酶凝乳酶和胃蛋白酶A(chymosin and pepsin A)的安全性評價發(fā)布意見。據(jù)了解,這種食品酶來自哺乳山羊、羔羊及牛犢的皺胃,旨在用于奶酪生產的牛奶加工中。
經(jīng)過評估,專家小組認為,在預期的使用條件下,不能排除通過飲食接觸引起的過敏性致敏和誘發(fā)反應的風險,但這種情況發(fā)生的可能性很低。根據(jù)所提供的數(shù)據(jù),小組得出結論,該食品酶在預期的使用條件下不會引起安全問題。部分原文報道如下:
The food enzyme containing chymosin (EC 3.4.23.4) and pepsin A (EC 3.4.23.1) is prepared from the abomasum of suckling goats, lambs and calves by Laboratoires Abia. The food enzyme is intended to be used in milk processing for cheese production. As no concerns arise from the animal source of the food enzyme or from its manufacture, and based on the history of safe use and consumption, the Panel considered that toxicological data and the estimation of dietary exposure were not required. On the basis of literature data, the Panel considered that, under the intended conditions of use, the risk of allergic reactions by dietary exposure could not be excluded, but the likelihood for this to occur was considered low. based on the data provided, the Panel concluded that this food enzyme does not give rise to safety concerns under the intended conditions of use.
編輯:qysb005